Sertindole

This classification denotes a serotonin antagonist and dopamine antagonist with the molecular formula C24H26ClFN4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GVV4Z879SP, chemically known as 2-imidazolidinone, 1-(2-(4-(5-chloro-1-(4-fluorophenyl)-1h-indol-3-yl)-1-piperidinyl)ethyl)- but generally known as sertindole, which bears US NIH Compound Identifier 60149. European Medicines Agency schedules Sertindole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10498MIG. The term SERTINDOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules sertindole in its Anatomical Therapeutic Chemical (ATC) Classification. SERTINDOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sertindole under HS 29333999 and SITC 51574. As of Q4 2014, SERTINDOLE remains the US FDA Preferred Term for this commodity. Sertindole bears US NLM identifiers UMLS ID C0084528 and NCI Concept Code C73295. SMILES: CLC1CC2C(C3CCN(CC3)CCN3CCNC3=O)CN(C2CC1)C1CCC(F)CC1.